Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Astaxanthin as a Novel Therapy for Asthma Management in Polluted Environments

NCT07507682 is registered in ClinicalTrials.gov with Middlesex University as lead sponsor.

NCT NCT07507682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07507682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Astaxanthin as a Novel Therapy for Asthma Management in Polluted Environments
Lead sponsor
Middlesex University
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2026
Completion date
July 20, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

airway hyperresponsiveness, airway inflammation, asthma (diagnosis)